Assignee
VELICEPT THERAPEUTICS INC
US·9 granted patents·4 pending applications·66 citations·filing 2013–2020
Top patents by PatentIndex Score
13 records- 0194US10065922B2Solabegron zwitterion and uses thereofVELICEPT THERAPEUTICS INC·Filed 2016·Granted Sep 4, 2018·9 cites·126 claims
- 0293US10221126B2Solabegron zwitterion and uses thereofVELICEPT THERAPEUTICS INC·Filed 2018·Granted Mar 5, 2019·4 cites·9 claims
- 0393US9907767B2Pharmaceutical compositions and the treatment of overactive bladderVELICEPT THERAPEUTICS INC·Filed 2017·Granted Mar 6, 2018·10 cites·42 claims
- 0492US10350182B2Pharmaceutical compositions and the treatment of overactive bladderVELICEPT THERAPEUTICS INC·Filed 2018·Granted Jul 16, 2019·6 cites·16 claims
- 0592US9522129B2Pharmaceutical CombinationVELICEPT THERAPEUTICS INC·Filed 2013·Granted Dec 20, 2016·14 cites·16 claims
- 0690US10844004B2Solabegron zwitterion and uses thereofVELICEPT THERAPEUTICS INC·Filed 2019·Granted Nov 24, 2020·2 cites·13 claims
- 0790US9956194B2Compositions and methods of using modified release solabegron for lower urinary tract symptomsVELICEPT THERAPEUTICS INC·Filed 2015·Granted May 1, 2018·18 cites·60 claims
- 0884US10668034B2Pharmaceutical compositions and the treatment of overactive bladderVELICEPT THERAPEUTICS INC·Filed 2019·Granted Jun 2, 2020·1 cites·16 claims
- 0983US10751311B2Compositions and methods of using modified release solabegron for lower urinary tract symptomsVELICEPT THERAPEUTICS INC·Filed 2018·Granted Aug 25, 2020·2 cites·16 claims
- 1065US2020246292A1Pharmaceutical compositions and the treatment of overactive bladderVELICEPT THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 1154US2017035716A1Method of using solabegronVELICEPT THERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 1242US2017348288A1Dosing regimens for beta-3 adrenoceptor agonists and anti-muscarinic agents for the treatment and prevention of lower urinary tract symptoms and overactive bladderVELICEPT THERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 1342US2017348263A1Compositions and methods of using modified release solabegron for lower urinary tract symptomsVELICEPT THERAPEUTICS INC·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when VELICEPT THERAPEUTICS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →